Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Published (Last):||27 June 2010|
|PDF File Size:||3.56 Mb|
|ePub File Size:||7.88 Mb|
|Price:||Free* [*Free Regsitration Required]|
Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. There were no deaths or embolism.
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine plazminogeno to clinical practice. Si continua navegando, consideramos que acepta su uso. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
There was a problem providing the content you requested
Print Send to a friend Export reference Mendeley Statistics. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
March Pages ee24 Pages Subscribe to our Newsletter. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up. They received between 1 to 5 cycles with rTPA. CiteScore measures average citations received per document published.
Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. This item has received.
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. The patients included 4 males with a mean weight of gr. Are you a health professional able to prescribe or dispense recombinnte Subscriber If you already have your login data, please click here.
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. In 4 patients complete resolution of the thrombus was achieved in a mean of 3.
Nine issues are published each year, including mostly originals, reviews and consensus documents. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.
You can change the settings or obtain more information by clicking here. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns.
Continuing navigation will be considered as acceptance of this use. Previous article Next article. From Monday to Friday from 9 a. SRJ is a prestige metric based on the idea that not all citations are recombinanye same.
Three patients received low molecular weight heparin prior to using rTPA. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.